Glycomics in Canada receives crucial funding boost to further life-saving research and biotechnology development.
In BIOTECanada’s Insights Magazine, GlycoNet Scientific Director Warren Wakarchuk writes about the importance of glycomics, opportunities to leverage glycomics, and Canadian glycomics expertise.
Read about the future of glycomics in this op ed by GlycoNet board chair Karimah Es Sabar, republished from the Hill Times. Canada has a tremendous opportunity with continued investment in glycomics to establish global leadership and economic prosperity while at the same time solving some of the world’s most pressing challenges in health and environmental sustainability.
In our new report: Why glycomics, the study of sugars on cells, is at the centre of a new surge of scientific and industry interest.
The meeting developed closer ties between the glycomics communities in Canada, Australia, and Taiwan.
By Chardelle Prevatt On Monday, September 19, 2016, GlycoNet scientists joined an elite group of industry experts in Montréal to discuss glycomics and oncology (glyco-oncology). Featuring Dr. Greg Plowman, VP (oncology research) at Eli Lilly and Company; Dr. Fred Sweeney, VP (business development and strategic alliances) at bioMerieux; and Dr. Luc Marengere, Managing Partner of TVM Capital Life Science, the panel offered invaluable […]